The G6PD*A (A376G) mutation observed in the study is a common variant, resulting in close to normal (~ 85%) enzyme activity of a non-deficient person, without significant clinical manifestations of G6PD-related haemolysis or appearing to confer resistance to malaria [5, 21, 24–27]. This evidence concerns the gene G6PD and malaria.